Sheng Ding Gladstone Institutes

Big stem cell news: dynamic duo of all-chemical direct reprogramming reports - The Niche

Gladstone Institutes, The Stem Cellar

Leadership Tenaya Therapeutics

Using CRISPR To Produce Induced Pluripotent Stem Cells

Sheng Ding Gladstone Institutes

Home Gladstone Institutes

Sheng Ding - Co-Founder - Tenaya Therapeutics

Researchers create first stem cells using CRISPR genome activation

Sheng Ding Gladstone Institutes

Home Gladstone Institutes

Scientists Create First Stem Cells Using CRISPR Technology

Sheng Ding

Investigators Gladstone Institutes

Gladstone Institute Spinout Tenaya Therapeutics Launches With $50 Million